<DOC>
	<DOC>NCT01688297</DOC>
	<brief_summary>The purpose of this study is to demonstrate the safety and immunogenicity of an oral vaccine to prevent seasonal influenza. Volunteers will receive placebo as part of the study.</brief_summary>
	<brief_title>Safety Study of an Oral Vaccine to Prevent Seasonal Influenza</brief_title>
	<detailed_description />
	<mesh_term>Influenza, Human</mesh_term>
	<criteria>In good health as established by medical history, physical examination, and laboratory testing at the time of enrollment. Positive for H1 influenza by HAI. Has had an influenza vaccine in the past 2 years. Current history of chronic alcohol consumption and/or illicit and/or recreational drug use. History of any confirmed or suspected immunodeficient or immunosuppressive condition Positive serology for HIV, HCV, or HBV Previous serious reactions to vaccination such as anaphylaxis, respiratory problems, hives, or abdominal pain. History of irritable bowel disease or other inflammatory digestive or gastrointestinal conditions that could affect the intended distribution of the vaccine targeting the mucosa of the small intestine Use of proton pump inhibitors(Nexium, Prilosec). Stool sample with occult blood at baseline exam</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>49 Years</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Influenza</keyword>
	<keyword>H1N1</keyword>
	<keyword>flu</keyword>
	<keyword>seasonal</keyword>
</DOC>